Concepedia

Author

M J Owens

Emory University

Also Known As

M J Owens, MICHAEL J. OWENS, Michael J. Owens

9

Publications

1.2K

Citations

9

H-Index

27

Concepts

All Affiliations

Emory UniversityDuke Medical CenterDuke University Hospital
MJ

About

M J Owens is an author at Emory University specializing in medicine, biological psychiatry, and social sciences.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

811

2

Social Sciences

3

3

735

3

Endocrinology

3

3

782

4

Neuroscience

3

3

735

5

Neurology

2

2

706

M J Owens

×

7

Publications

986

Citations

7

H-Index

YearCitations

Persistent changes in corticotropin-releasing factor neuronal systems induced by maternal deprivation.

Charlotte O. Ladd, M J Owens, Charles B. Nemeroff

Endocrinology

1996

499

Persistent changes in corticotropin-releasing factor systems due to early life stress: relationship to the pathophysiology of major depression and post-traumatic stress disorder.

Christine Heim, M J Owens, P M Plotsky,

PubMed

1997

207

Chronic Administration of the Selective Corticotropin-Releasing Factor 1 Receptor Antagonist CP-154,526: Behavioral, Endocrine and Neurochemical Effects in the Rat

Lotta Arborelius, Kelly Skelton, K. V. Thrivikraman,

Journal of Pharmacology and Experimental Therapeutics

2000

102

5a-Pregnane-3a,21-diol-20-one (THDOC) attenuates mild stress-induced increases in plasma corticosterone via a non-glucocorticoid mechanism: comparison with alprazolam

M J Owens, James Ritchie, Charles B. Nemeroff

Brain Research

1992

76

Alterations in the hypothalamic-pituitary-adrenal axis in a proposed animal model of depression with genetic muscarinic supersensitivity.

M J Owens, David H. Overstreet, D L Knight,

PubMed

1991

46

The serotonergic antidepressant nefazodone inhibits the serotonin transporter: In vivo and ex vivo studies

M J Owens, John R. leni, David L Knight,

Life Sciences

1995

29

The 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane stimulates the hypothalamic-pituitary-adrenal (HPA) axis. II. Biochemical and physiological evidence for the development of tolerance after chronic administration.

M J Owens, David L Knight, James Ritchie,

Journal of Pharmacology and Experimental Therapeutics

1990

27

Page 1